Background: To compare the publication and citation rate within the areas of drug abuse and dependence research in Europe with that in the USA. Methods: This is a bibliometric study using the Thomson Reuters Web of Knowledge as data source, 40 key words were used as search terms, but certain scientific publications not concerning the issue were excluded. Scientific publications from Denmark, England, Finland, France, Germany, Italy, the Netherlands, Norway, Spain, Sweden, and the USA were studied. The number of publications in each country and in each year in addition to the citation indices for these publications was retrieved. Results: Approximately two thirds of the publications came from the USA. Both in absolute and relative figures, Europe lagged behind. The trend over the last decade was a greater gap between the amount of research performed in Europe versus the USA. There were thematic differences. Smaller European countries had a greater relative publication rate. The citations were relatively evenly distributed. Conclusions: It has been claimed that 85% of the world's research within the field of drug abuse and dependence is carried out in the USA. This study challenges this figure, but European research within this field is lagging behind.

Keywords:
Abuse and dependence, European versus USA research
1.
Moed H, Burger J, Frankfort J, van Raan A: The use of bibliometric data for the measurement of university research performance. Res Policy 1985;14:131-149.
2.
Valderrama Zurian JC, Aleixander R, Castellano M: Citation count analysis in addiction (2001). Addiction 2004;99:387-388.
3.
West R, McIlwaine A: What do citation counts count for in the field of addiction? An empirical evaluation of citation counts and their link with peer ratings of quality. Addiction 2002;97:501-504.
4.
NIDA: Fiscal Year 2012 Budget Information - Congressional Justification for National Institute on Drug Abuse. June 5, 2012.
5.
NIDA: NIDA - National Institute of Drug Abuse. June 5, 2012.
6.
Mann K: Why should we need a European Federation of Addiction Societies? Addiction 2012;107:692-693.
7.
Sanchez-Carbonell X, Guardiola E, Belles A, Beranuy M: European Union scientific production on alcohol and drug misuse (1976-2000). Addiction 2005;100:1166-1174.
8.
Carroll KM: Dissemination of evidence-based practices: how far we've come, and how much further we've got to go. Addiction 2012;107:1031-1033.
9.
Donaldson C, Mugford M, Vale L: Evidence-Based Health Economics: From Effectiveness to Efficiency in Systematic Reviews. London, BMJ Books, 2002.
10.
Sellman D: The 10 most important things known about addiction. Addiction 2010;105:6-13.
11.
WHO: The Global Burden of Disease: 2004 Update. Geneva, WHO, 2008.
12.
Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, et al: The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011;21:655-679.
13.
Effertz T, Mann K: The burden and cost of disorders of the brain in Europe with the inclusion of harmful alcohol use and nicotine addiction. Eur Neuropsychopharmacol 2012 (E-pub ahead of print).
14.
Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, et al: Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011;21:718-779.
15.
Degenhardt L, Hall W: Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012;379:55-70.
16.
Jones AW: The distribution of forensic journals, reflections on authorship practices, peer review and role of the impact factor. Forensic Sci Int 2007;165:115-128.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.